Presence of multimeric isoforms of human C-reactive protein in tissues and blood

Qiling Li1, Wei Xu2, Xue Xue1

  • 1Department of Obstetrics and Gynecology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Molecular Medicine Reports
|November 15, 2016
PubMed

Insights

C-reactive protein (CRP) exists beyond its usual pentamer form. Researchers found trimeric and tetrameric CRP in blood and tissues, suggesting conformation analysis is crucial for disease studies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • C-reactive protein (CRP) concentration is a known disease biomarker.
  • CRP is typically measured as a pentameric isoform in clinical settings.
  • The presence of other CRP isoforms and their significance remain largely unexplored.

Purpose of the Study:

  • To investigate the existence of different C-reactive protein (CRP) isoforms in blood.
  • To examine CRP conformations beyond the standard pentameric form.
  • To determine if these isoforms are associated with age and present in various tissues.

Main Methods:

  • Generation and genotyping of transgenic rats expressing human CRP.
  • Non-reducing western blotting on blood and tissues from transgenic rats and human patients.
  • Enzyme-linked immunosorbent assay (ELISA) for CRP concentration in human blood.

Main Results:

  • Detection of trimeric and tetrameric CRP isoforms in addition to the pentameric form in transgenic rat blood.
  • Trimeric and tetrameric CRP were found in various tissues of older transgenic rats.
  • Confirmation of additional CRP isoforms in human blood samples using non-reducing western blotting.

Conclusions:

  • C-reactive protein (CRP) exists in multiple isoforms, including trimers and tetramers, in addition to the commonly measured pentamer.
  • These alternative CRP isoforms appear to be age-associated and present in diverse tissues.
  • CRP conformation analysis, alongside concentration, may be necessary for accurate clinical and epidemiological disease assessment.